Quantitative analysis of lymph vessel characteristics in organ confined prostate cancer

Prostate

Volumn 71, Issue 1, 2011, Pages 91-97

  Van Niekerk, Cornelis G ^a   Hulsbergen Van De Kaa, Christina A ^a   Barentsz, Jelle O ^a   Witjes, J Alfred ^a   Van Der Laak, Jeroen A W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

digital image analysis; lymphangiogenesis; prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH VESSEL; LYMPHATIC PARAMETERS; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE ANALYSIS; TUMOR VASCULARIZATION;

ADENOCARCINOMA; AGED; HUMANS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 78649537035     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21225     Document Type: Article

References (18)

1. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101.
2. Straume O, Jackson DG, Akslen LA,. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250-256.
3. Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H,. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 2004; 40: 358-364.
4. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K,. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998; 58: 1599-1604.
5. Kahn HJ, Marks A,. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002; 82: 1255-1257.
6. Ebata N, Nodasaka Y, Sawa Y, Yamaoka Y, Makino S, Totsuka Y, Yoshida S,. Desmoplakin as a specific marker of lymphatic vessels. Microvasc Res 2001; 61: 40-48.
7. Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R,. Lymph and blood vessel architecture in benign and malignant prostatic tissue: Lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 2004; 172: 103-107.
8. Soh S, Ishii T, Sato E, Akishima Y, Ito K, Baba S,. Topographic distribution of lymphatic vessels in the normal human prostate. Prostate 2005; 63: 330-335.
9. Fukuda H, Yamada T, Kamata S, Saitoh H,. Anatomic distribution of intraprostatic lymphatics: Implications for the lymphatic spread of prostate cancer-A preliminary study. Prostate 2000; 44: 322-327.
10. Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED,. Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 2005; 65: 222-230.
11. Roma AA, Magi-Galluzzi C, Kral MA, Jin TT, Klein EA, Zhou M,. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol 2006; 19: 392-398.
12. van Oort IM, Bruins HM, Kiemeney LA, Knipscheer BC, Witjes JA, Hulsbergen-van de Kaa CA,. The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy. Histopathol 2010; 56: 464-471.
13. Epstein JI, Allsbrook WC, Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242.
14. van Niekerk CG, van der Laak JAWM, Borger ME, Huisman HJ, Witjes JA, Barentsz JO, Hulsbergen-van de Kaa CA,. Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue. Prostate 2009; 69: 62-69.
15. Vlems F, van der Worp E, van der Laak JAWM, van de Velde C, Nagtegaal I, van Krieken JHJM,. A study into methodology and application of quantification of tumour vasculature in rectal cancer. Virchows Arch 2004; 445: 263-270.
16. Cheng L, Bishop E, Zhou H, Maclennan GT, Lopez-Beltran A, Zhang S, Badve S, Baldridge LA, Montironi R,. Lymphatic vessel density in radical prostatectomy specimens. Hum Pathol 2008; 39: 610-615.
17. Kim HS, Sung W, Lee S, Chang SG, Park YK,. Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea. Pathol Res Pract 2009; 205: 249-254.
18. Trojan L, Rensch F, Voss M, Grobholz R, Weiss C, Jackson DG, Alken P, Michel MS,. The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int 2006; 98: 903-906.